Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).
about
Pancreatic regulation of glucose homeostasisA GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control.GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetesUbiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?The emerging role of the intestine in metabolic diseases.Structural aspects of gut peptides with therapeutic potential for type 2 diabetes.Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
P2860
Q26766485-F2922ABC-7BF5-4F8C-B395-6864D3D663E3Q33541007-51BCC8BA-6335-4AC4-9C04-30D8DA696666Q34718860-7D8A397E-95B4-479C-9033-2F7D484D785EQ37093181-47D60128-A07E-4FC2-8ECF-2EFA2A92E30BQ37779101-27197330-4650-4E2E-87B4-43A8FBDA9F4FQ37889275-F058D912-4260-492D-A500-33A2BEBBB637Q38071991-ADBF6E53-21EE-41A5-A882-16281AD9F437Q38337206-EAA62914-FDDA-49D9-BE59-1AF7FE7C5702
P2860
Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37).
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@ast
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@en
type
label
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@ast
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@en
prefLabel
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@ast
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@en
P2093
P2860
P50
P356
P1433
P1476
Antidiabetic potential of two ...... sPAL16) and N-AcGIP(LysPAL37).
@en
P2093
Brett Greer
Brian D Green
Clifford J Bailey
Finbarr P M O'Harte
Patrick Harriott
P2860
P304
P356
10.1515/BC.2005.079
P577
2005-07-01T00:00:00Z